[Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children].
The plasma-exchange has been recently adopted in the therapy of the hemolytic-uremic syndrome. We experimented this therapy, without any complication with traditional treatment (anti platelet-aggregation, frozen fresh plasma), on a child of 6 years and 8 months old. A rapid normalization of the clinical syntomatology was obtained without sequences also after a long period. The PE therapy has to be carefully valued on the solution of the SUE in order to establish the cases to be treated, missing proved results from controlled experiments.
D001241:Aspirin / Q000627:therapeutic use; D001803:Blood Transfusion; D002648:Child; D003131:Combined Modality Therapy; D004176:Dipyridamole / Q000627:therapeutic use; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D010956:Plasmapheresis
D004176:Dipyridamole; D001241:Aspirin
Sull'impiego della plasmaferesi nel trattamento della sindrome uremico-emolitica nel bambino.